Cite
HARVARD Citation
Fracasso, P. et al. (2022). A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies. American journal of clinical oncology. pp. 294-297. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fracasso, P. et al. (2022). A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies. American journal of clinical oncology. pp. 294-297. [Online].